Stock listing
NASDAQ:GBT Global Blood Therapeutics Inc Stock
Follow Global Blood Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:GBT
$68.49 USD
Close on Oct 5, 2022 · No longer trades
- Lowest – highest close
- $12.95 – $87.20 USDSince Aug 11, 2015 · lowest Feb 9, 2016 · highest Jan 16, 2020
Delisted NASDAQ:GBT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:GBT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Global Blood Therapeutics Inc on 6ix
- Calls
- 6 calls with a replay · 6 with a transcript · latest May 4, 2022
- Decks
- 1 deck · latest Aug 18, 2022
Events
| Call | When | Status |
|---|---|---|
| Global Blood Therapeutics (GBT) Q1 2022 Earnings Call | Wed, May 04, 2022 · 4:30 PM ET | Replay |
| Global Blood Therapeutics (GBT) Q4 2021 Earnings Call | Wed, Feb 23, 2022 · 4:30 PM ET | Replay |
| Global Blood Therapeutics (GBT) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 4:30 PM ET | Replay |
| Global Blood Therapeutics (GBT) Q2 2021 Earnings Call | Tue, Aug 03, 2021 · 4:30 PM ET | Replay |
| Global Blood Therapeutics (GBT) Q1 2021 Earnings Call | Wed, May 05, 2021 · 4:30 PM ET | Replay |
| Global Blood Therapeutics (GBT) Q4 2020 Earnings Call | Wed, Feb 24, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (August 2022) | Merger or acquisition | 11 slides | Aug 18, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dawn Svoronos Other companies: Adverum Biotechnologies Inc (Director · Since at least Dec 9, 2020); Xenon Pharmaceuticals Inc. (Director · Since at least Sep 27, 2016); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Endocyte Inc (Director · May 3, 2018 – Dec 21, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2016 – Jun 9, 2022 · Past); Medivation Inc (Director · Apr 22, 2013 – Sep 28, 2016 · Past) | Director · Dec 19, 2018 – Oct 5, 2022 · Past |
| Deval Patrick Other companies: Toast, Inc. (Board Member · Since at least Sep 21, 2021); Twilio Inc. (Director · Since at least Jan 13, 2021); Cerevel Therapeutics Holdings Inc (Director · Jan 20, 2021 – Aug 1, 2024 · Past); Environmental Impact Acquisition Corp. (Director · Jan 13, 2021 – Jan 13, 2021 · Past); American Well Corporation (Director · Sep 16, 2020 – Jun 22, 2023 · Past); SpringWorks Therapeutics Inc (Director · Sep 12, 2019 – Sep 12, 2019 · Past) | Director · Aug 11, 2015 – Oct 5, 2022 · Past |
| Jeffrey Farrow Other companies: Achieve Life Sciences, Inc. (Director · Since at least May 29, 2026); Tarsus Pharmaceuticals, Inc. (See Remarks · Since at least Apr 24, 2023); Lisata Therapeutics, Inc. (Director · Since Oct 13, 2026 · Appointed, no departure found); ZS Pharma Inc (Chief Financial Officer · Jul 8, 2015 – Dec 17, 2015 · Past); Hyperion Therapeutics Inc (CFO · Jul 25, 2012 – May 7, 2015 · Past); Renovis Inc (V.P., Finance and CAO · Jul 1, 2007 – May 2, 2008 · Past) | Chief Financial Officer · Apr 4, 2016 – Oct 5, 2022 · Past |
| Kevin P Starr Other companies: MyoKardia Inc (Director · Oct 28, 2015 – Mar 7, 2018 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Jun 15, 2023 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – Sep 24, 2015 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Feb 19, 2015 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2017 · Past); Human Genome Sciences Inc (Director · May 3, 2007 – Jul 10, 2007 · Past) | Director · Aug 11, 2015 – Aug 17, 2015 · Past |
| Charles Homcy Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); BridgeBio Pharma, Inc. (Director · Since at least Jun 27, 2019); Population Health Investment Co Inc (Director · Nov 17, 2020 – Jan 26, 2021 · Past); Pliant Therapeutics, Inc. (Director · Jun 2, 2020 – Jun 29, 2021 · Past); Portola Pharmaceuticals Inc (Director · Jun 8, 2018 – Jan 2, 2019 · Past) | Director · Oct 3, 2017 – Jun 20, 2018 · Past |
| David E. Johnson Other companies: Exelixis, Inc. (Director · Since at least Nov 5, 2026); Vera Therapeutics, Inc. (Chief Operating Officer · Since at least Jul 1, 2024); Caribou Biosciences, Inc. (Chief Operating Officer · Since at least May 11, 2022) | Chief Commercial Officer · Mar 13, 2018 – Oct 5, 2022 · Past |
| Joshua Lehrer-Graiwer Other companies: Lisata Therapeutics, Inc. (President & COO · Since at least Sep 17, 2026); Fulcrum Therapeutics, Inc. (Director · Since at least Apr 23, 2026); LENZ Therapeutics, Inc. (PRESIDENT AND CEO, Director · Jan 13, 2021 – Feb 21, 2023 · Past) | Chief Medical Officer · Oct 1, 2019 – Mar 5, 2020 · Past |
| Mark L Perry Other companies: MyoKardia Inc (Director · Oct 28, 2015 – Nov 17, 2020 · Past); NVIDIA Corporation (Director · May 20, 2010 – Jun 26, 2024 · Past) | Director · Aug 11, 2015 – Oct 5, 2022 · Past |
| Carrie Krehlik Other companies: Adicet Bio, Inc. (Chief Human Resources Officer · Sep 15, 2020 – Feb 12, 2021 · Past) | Chief Human Resources Officer · Aug 2, 2021 – Oct 5, 2022 · Past |
| Glenn Pierce Other companies: Voyager Therapeutics, Inc. (Director · Since at least Jan 1, 2017) | Director · Feb 8, 2016 – Oct 5, 2022 · Past |
All 12 people
| Person | Seat |
|---|---|
| Philip A Pizzo Other companies: ClearPoint Neuro Inc. (Director · Jun 30, 2015 – Oct 4, 2017 · Past) | Director · Sep 23, 2015 – Oct 5, 2022 · Past |
| Nazila Habibizad | See Remarks · Mar 1, 2022 – Oct 5, 2022 · Past |
Log in to ask 6ix AI your own questions about Global Blood Therapeutics Inc.